Literature DB >> 22231297

Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.

Claudia Gundacker1, Helmut Dolznig, Mario Mikula, Margit Rosner, Oliver Brandau, Markus Hengstschläger.   

Abstract

Male infertility is a major public health issue predominantly caused by defects in germ cell development. In the past, studies on the genetic regulation of spermatogenesis as well as on negative environmental impacts have been hampered by the fact that human germ cell development is intractable to direct analysis in vivo. Compared with model organisms including mice, there are fundamental differences in the molecular processes of human germ cell development. Therefore, an in vitro model mimicking human sperm formation would be an extremely valuable research tool. In the recent past, both human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells have been reported to harbour the potential to differentiate into primordial germ cells and gametes. We here discuss the possibility to use human amniotic fluid stem (AFS) cells as a biological model. Since their discovery in 2003, AFS cells have been characterized to differentiate into cells of all three germ layers, to be genomically stable, to have a high proliferative potential and to be non-tumourigenic. In addition, AFS cells are not subject of ethical concerns. In contrast to iPS cells, AFSs cells do not need ectopic induction of pluripotency, which is often associated with only imperfectly cleared epigenetic memory of the source cells. Since AFS cells can be derived from amniocentesis with disease-causing mutations and can be transfected with high efficiency, they could be used in probing gene functions for spermatogenesis and in screening for male reproductive toxicity.

Entities:  

Mesh:

Year:  2012        PMID: 22231297      PMCID: PMC3735087          DOI: 10.1038/aja.2011.170

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  75 in total

Review 1.  The X chromosome and ovarian failure.

Authors:  R M Davison; C J Davis; G S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  1999-12       Impact factor: 3.478

Review 2.  Sex matters in meiosis.

Authors:  Patricia A Hunt; Terry J Hassold
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

3.  Derivation of oocytes from mouse embryonic stem cells.

Authors:  Karin Hübner; Guy Fuhrmann; Lane K Christenson; James Kehler; Rolland Reinbold; Rabindranath De La Fuente; Jennifer Wood; Jerome F Strauss; Michele Boiani; Hans R Schöler
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

4.  The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes.

Authors:  Helen Skaletsky; Tomoko Kuroda-Kawaguchi; Patrick J Minx; Holland S Cordum; LaDeana Hillier; Laura G Brown; Sjoerd Repping; Tatyana Pyntikova; Johar Ali; Tamberlyn Bieri; Asif Chinwalla; Andrew Delehaunty; Kim Delehaunty; Hui Du; Ginger Fewell; Lucinda Fulton; Robert Fulton; Tina Graves; Shun-Fang Hou; Philip Latrielle; Shawn Leonard; Elaine Mardis; Rachel Maupin; John McPherson; Tracie Miner; William Nash; Christine Nguyen; Philip Ozersky; Kymberlie Pepin; Susan Rock; Tracy Rohlfing; Kelsi Scott; Brian Schultz; Cindy Strong; Aye Tin-Wollam; Shiaw-Pyng Yang; Robert H Waterston; Richard K Wilson; Steve Rozen; David C Page
Journal:  Nature       Date:  2003-06-19       Impact factor: 49.962

5.  Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation.

Authors:  Pieternella S In 't Anker; Sicco A Scherjon; Carin Kleijburg-van der Keur; Willy A Noort; Frans H J Claas; Roelof Willemze; Willem E Fibbe; Humphrey H H Kanhai
Journal:  Blood       Date:  2003-08-15       Impact factor: 22.113

6.  A molecular programme for the specification of germ cell fate in mice.

Authors:  Mitinori Saitou; Sheila C Barton; M Azim Surani
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

7.  Proliferation potential of human amniotic fluid stem cells differently responds to mercury and lead exposure.

Authors:  C Gundacker; M Scheinast; L Damjanovic; C Fuchs; M Rosner; M Hengstschläger
Journal:  Amino Acids       Date:  2011-11-19       Impact factor: 3.520

8.  Infertility, blood mercury concentrations and dietary seafood consumption: a case-control study.

Authors:  Christine M Y Choy; Christopher W K Lam; Lorena T F Cheung; Christine M Briton-Jones; L P Cheung; Christopher J Haines
Journal:  BJOG       Date:  2002-10       Impact factor: 6.531

9.  The human VASA gene is specifically expressed in the germ cell lineage.

Authors:  D H Castrillon; B J Quade; T Y Wang; C Quigley; C P Crum
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

10.  Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?

Authors:  Andrea-Romana Prusa; Erika Marton; Margit Rosner; Gerhard Bernaschek; Markus Hengstschläger
Journal:  Hum Reprod       Date:  2003-07       Impact factor: 6.918

View more
  4 in total

Review 1.  Amniotic stem cells as a source of regenerative medicine to treat female infertility.

Authors:  Aisha Naeem; Nikita Gupta; Usra Naeem; Mohamed A Elrayess; Chris Albanese
Journal:  Hum Cell       Date:  2022-10-17       Impact factor: 4.374

Review 2.  Amniotic fluid stem cells to study mTOR signaling in differentiation.

Authors:  Margit Rosner; Katharina Schipany; Bharanidharan Shanmugasundaram; Gert Lubec; Oliver Brandau; Markus Hengstschläger
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

3.  Amniotic fluid stem cells: future perspectives.

Authors:  Margit Rosner; Katharina Schipany; Bharanidharan Shanmugasundaram; Gert Lubec; Markus Hengstschläger
Journal:  Stem Cells Int       Date:  2012-06-06       Impact factor: 5.443

Review 4.  Stem Cell Therapies for Human Infertility: Advantages and Challenges.

Authors:  Jin-Xiang Wu; Tian Xia; Li-Ping She; Shu Lin; Xiang-Min Luo
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.